According to Rockwell Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.509241. At the end of 2023 the company had a P/S ratio of 0.6440.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.6440 | 297.12% |
2022 | 0.1622 | -73.93% |
2021 | 0.6221 | -59.06% |
2020 | 1.52 | -41.61% |
2019 | 2.60 | 27.97% |
2018 | 2.03 | -61.32% |
2017 | 5.26 | -17% |
2016 | 6.33 | -33.52% |
2015 | 9.53 | -0.12% |
2014 | 9.54 | 19.32% |
2013 | 7.99 | 130.29% |
2012 | 3.47 | 7.52% |
2011 | 3.23 | 38.98% |
2010 | 2.32 | -3.87% |
2009 | 2.42 | 115.41% |
2008 | 1.12 | -51.31% |
2007 | 2.30 | -19.18% |
2006 | 2.85 | 100.96% |
2005 | 1.42 | -5.54% |
2004 | 1.50 | -54.11% |
2003 | 3.27 | 436.5% |
2002 | 0.6101 | -61.15% |
2001 | 1.57 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 4.65 | 813.33% | ๐บ๐ธ USA |
Baxter BAX | 1.37 | 168.77% | ๐บ๐ธ USA |
Mesa Laboratories MLAB | 2.61 | 411.67% | ๐บ๐ธ USA |
ICU Medical
ICUI | 1.02 | 101.24% | ๐บ๐ธ USA |